Rutherford P A, Thomas T H, O'Kelly J, West I C, Wilkinson R
Department of Medicine (Nephrology), Freeman Hospital, Newcastle-upon-Tyne, UK.
Nephron. 1996;72(2):184-8. doi: 10.1159/000188839.
Uraemia affects erythrocyte metabolism and membrane function but no consistent effect on Na/Li countertransport (CT) has been reported. We report only small differences in Na/Li CT at 150 mmol/l Na over haemodialysis, but major differences in other properties of Na/Li CT. The Km for external sodium and Vmax both increased during haemodialysis but the Vmax/Km ratio, which was greater than normal, was not affected. The thiol reagent, N-ethylmaleimide (NEM), which causes a decrease in Km and Vmax in normal subjects, had no effect on Km in the predialysis erythrocytes. After haemodialysis, the sensitivity of Na/Li CT to NEM was improved. The changes in Na/Li CT kinetics were not related to changes in membrane lipid fluidity or plasma lipids. These observations suggest that uraemia affects a thiol group that controls Na/Li CT kinetics and that haemodialysis temporarily improves this aspect of membrane function.
尿毒症会影响红细胞代谢和膜功能,但关于钠/锂逆向转运(CT),尚未有一致的影响报道。我们报告称,在血液透析过程中,当钠浓度为150 mmol/l时,钠/锂CT仅有微小差异,但在钠/锂CT的其他特性上存在重大差异。血液透析期间,外部钠的米氏常数(Km)和最大反应速度(Vmax)均升高,但大于正常水平的Vmax/Km比值未受影响。硫醇试剂N-乙基马来酰亚胺(NEM)可使正常受试者的Km和Vmax降低,但对透析前红细胞的Km无影响。血液透析后,钠/锂CT对NEM的敏感性提高。钠/锂CT动力学的变化与膜脂流动性或血浆脂质的变化无关。这些观察结果表明,尿毒症会影响控制钠/锂CT动力学的硫醇基团,而血液透析可暂时改善膜功能的这一方面。